Green Tea Leaf Extract

Overall Health Benefits of Green Tea Leaf Extract

• Improves symptoms of diabetes [1-8]
• Lowers blood pressure [9-15]
• Boosts sexual vitality and improves sexual health [16-24]
• Speeds up wound healing [25-27]
• Prevents and treats nerve damage [28-30]
• Lowers risk of stroke [31-37]
• Lowers risk of cardiovascular disease [36-44]
• Prevents Alzheimer’s disease (AD) and boosts cognitive health [45-52]
• Prevents cancer [53-104]
• Wards off depression and improves mood [105-109]

How Green Tea Leaf Extract Works

Green tea contains 2-4% caffeine that can boost thinking and alertness, increase urine output, and improve overall mood. It also contains various beneficial substances such as antioxidants, polyphenols, flavonoids, vitamin C, vitamin B2, folic acid, beta-carotene, vitamin E, theanine, saponins, fluorine, calcium, potassium, phosphorus, and manganese.

Proven Health Benefits of Green Tea Leaf Extract

Improves Symptoms of Diabetes

Several lines of clinical evidence show that green tea leaf extract has anti-diabetic properties:

1. A study found that long-term consumption of green tea leaf extract is beneficial against type 2 diabetes. [1]
2. A study reported that epigallocatechin gallate (EGCG) from green tea leaf has blood sugar-lowering properties. [2]
3. In diabetic rats, green tea leaf extract notably decreased blood sugar levels. [3]
4. A study found that the anti-diabetic properties of green tea leaf extract can be attributed to the amount of polyphenols and caffeine it contains. [4]
5. A 2019 study reported that green tea leaf extract can help protect against diabetes mellitus and its complications via several mechanisms such as enhancing insulin action, preventing insulin resistance, activating signaling pathways involved in insulin secretion, reducing the levels of free radicals, and decreasing inflammatory substances. [5]
6. A study also found that green tea leaf extract reduces blood sugar levels via its inhibitory effect against α-amylase and α-glucosidase in the digestive tract. [6]
7. A study also reported that green tea leaf extract can help normalize blood sugar levels by improving fat metabolism and preventing obesity. [7]
8. In diabetic patients, consumption of green tea leaf extract significantly reduced fasting blood glucose and hemoglobin. [8]

Lowers Blood Pressure

Evidence suggests that green tea leaf extract has antihypertensive properties:

1. In 13 trials comprising of a total of 1,367 subjects consumption of green tea leaf extract reduced blood pressure. [9]
2. In 24 trials composed of 1697 subjects, consumption of green tea leaf extract significantly reduced systolic blood pressure and diastolic blood pressure. [10]
3. In overweight and obese adults, supplementation with green tea leaf extract significantly reduced blood pressure [11]
4. A 2019 study reported that green tea leaf extract reduces blood pressure by relaxing smooth muscle via enhancement of endothelial nitric oxide synthase activity. [12]
5. A study found that green tea leaf extract can reduce blood pressure through its anti-obesity effects. [13]
6. In overweight and obese women, green tea leaf extract effectively reduced blood pressure by increasing leptin and reducing low density lipoprotein. [14]
7. A study found that tea catechins in green tea leaf extract can help reduce blood pressure. [15]

Boosts Sexual Vitality and Improves Sexual Health

Studies also show that green tea leaf extract can help treat sexual dysfunction:

1. In adult male albino rats, supplementation with green tea leaf extract improved sexual function. [16]
2. In male rats, consumption of green tea leaf extract led significant improvement in penile erection. [17-19]
3. In female hypertensive patients, consumption of green tea leaf extract was positively related with sexual orgasm and sexual satisfaction [20]
4. In rats, supplementation with green tea leaf extract improved ejaculation. [21]
5. In aged diabetic rats, the addition of green leaf extract to sildenafil treatment significantly improved penile erection. [22]
6. In male Wistar rats, supplementation with green tea leaf extract improved sperm parameters. [23-24]

Speeds Up Wound Healing

There’s also a good deal of evidence supporting the beneficial effects of green tea leaf extract on wound healing:

1. In Sprague Dawley rats, green tea leaf extract reduced inflammatory cells and increased collagen (protein necessary for wound repair) at the wound site. [25]
2. In male Wistar rats, healing duration was faster in the group treated with green tea leaf extract than those treated with normal saline. [26]
3. A study found that green tea leaf extract can help speed up wound healing through its antimicrobial properties. [27]

Prevents and Treats Nerve Damage

Several studies found that green tea leaf extract along with its components can help improve nerve health:

1. A study found that catechins in green tea leaf extract can be used in the prevention and treatment of neurodegenerative diseases. [28]
2. A study demonstrated that green tea leaf extract has anti-inflammatory effects which can help speed up nerve regeneration. [29]
3. A study found that the epigallocatechin-3-gallate from green tea leaf extract has potent analgesic effect against neuropathic pain (also known as nerve pain). [30]

Lowers Risk of Stroke

Evidence suggests that consumption of green tea leaf extract is beneficial in reducing one’s risk of stroke:

1. In middle-aged and older Korean men, higher consumption of green tea leaf extract was associated with a lower risk of stroke. [31]
2. An analysis of 14 studies composed of 513 804 participants found that green tea leaf extract consumption was associated with a decreased risk of stroke, particularly ischemic stroke (caused by reduced blood supply to the brain). [32]
3. A study reported that green tea leaf extract is a practical method for stroke prevention. [33]
4. In a rat model of stroke, researchers found that green tea leaf extract can help protect against stroke via inhibition of endoplasmic reticulum stress (a form of cell injury). [34]
5. In men and women with a history of stroke and heart disease, green tea leaf extract consumption reduced the risk of total stroke incidence, cerebral infarction (brain tissue death), and cerebral hemorrhage (bleeding in the brain). [35]
6. A review of 9 Japanese studies found that green tea leaf extract consumption (1-3 cups per day) reduced the incidence of stroke. [36]
7. Data from 9 studies involving 194 965 individuals found that green tea leaf extract consumption equaling 3 cups per day can help prevent ischemic stroke. [37]

Lowers Risk of Cardiovascular Disease

Studies also show that consumption of green tea leaf extract can significantly reduce the risk of cardiovascular disease:

1. A review of 9 Japanese studies found that consumption of 1-3 cups of green tea leaf extract daily was associated with a lower risk of cardiovascular disease. [36]
2. In male non-smokers, green tea leaf extract reduced the risk of stroke. [38]
3. In the middle-aged and older Chinese populations, green tea leaf extract consumption was associated with a reduced risk of coronary heart disease (CHD). [39-40]
4. A study found that green tea leaf extract can lower the risk of cardiovascular disease by inhibiting atherogenesis (plaque formation within the arteries). [41]
5. A review of several studies found that green tea leaf extract can improve heart health by enhancing endothelial function, reducing inflammation, and protecting cardiomyocyte (heart cells) function. [42]
6. In a large prospective study, researchers found that daily green tea leaf extract consumption was associated with a lower risk of ischemic heart disease (IHD). [43]
7. A study found that green tea catechins can significantly reduce the risk of cardiovascular disease. [44]

Prevents Alzheimer’s Disease (AD) and Boosts Cognitive Health

There’s also increasing evidence supporting the benefits of green tea leaf extract on AD and cognitive health:

1. A review of several studies found that higher consumption of green tea leaf extract was associated with a lower risk of dementia and AD. [45]
2. A review of several clinical trials also found that green tea leaf extract protects against AD by reducing the levels of amyloid beta (abnormal protein structures in the brain). [46]
3. A study found that catechins in green tea leaf extract improves cognitive health by preventing neuronal cell dysfunction and death in the brain. [47]
4. A study reported that regular consumption of green tea leaf extract can help improve memory and attention. [48]
5. In older adults, consumption of green tea leaf extract more than 4 times a day reduced the risk of cognitive decline. [49]
6. In mice, epigallocatechin-3-gallate from green tea leaf extract alleviated cognitive deficits. [50]
7. A study also found that epigallocatechin-3-gallate from green tea leaf extract exhibited protective effects against neuronal damage and brain inflammation. [51]
8. A study found that flavonoids in green tea leaf extract can help protect against various states of cognitive dysfunction, AD, and dementia. [52]

Prevents Cancer

The anti-cancer properties of green tea leaf extract are backed by an overwhelming body of clinical evidence:

1. Several studies found that epigallocatechin-3-gallate from green tea leaf extract can inhibit tumor growth and metastasis. [53-54]
2. In animal models, oral administration of green tea leaf extract resulted in significant reduction in tumor growth and invasion. [55-63]
3. In patients who had surgical removal of polyps (abnormal tissue growths), supplementation with Japanese-size cups of green tea daily and tablets of green tea extract significantly reduced the recurrence of colorectal cancer. [64]
4. Studies show that epigallocatechin-3-gallate from green tea leaf extract exerts its anti-cancer effects in models of lung cancer by inhibiting cancer cell proliferation and colony formation. [65-72]
5. In human colon cancer cells and animal models of colorectal cancer, epigallocatechin-3-gallate from green tea leaf extract suppressed the growth of cancer cells by inhibiting inflammation and signaling pathways necessary for survival. [73-79]
6. In human prostate cancer cells, epigallocatechin-3-gallate from green tea leaf extract induced programmed cell death (apoptosis), which in turn inhibited the growth and reproduction of cancer cells. [80-86]
7. A study found that green tea leaf extract alters the metabolic reprogramming of cancer cells, which in turn inhibits the propagation of cancer stem cells. [87]
8. Studies reported that higher green tea consumption was associated with a lower risk of breast cancer. [88-90]
9. In premenopausal patients with stage I and II breast cancer, increased consumption of green tea was associated with decreased numbers of breast cancer cells. [91]
10. In breast cancer patients, epigallocatechin-3-gallate potentiated the efficacy of radiation therapy. [92]
11. Several studies also found that higher green tea leaf extract consumption was associated with a lower risk of different types of cancer. [93-100]
12. Studies reported that the addition of green tea leaf extract in chemotherapy produces a more potent anti-cancer effect. [101-104]

Wards off Depression and Improves Mood

Consumption of green tea leaf extract can also help treat depression and improve overall mood:

1. In healthy individuals, oral administration of green tea leaf extract for 5 weeks increased reward learning and prevented depressive symptoms. [105]
2. A study reported that green tea leaf extract exerts its antidepressant effects by modulating the activity of the brain chemical known as dopamine. [106]
3. In the community-dwelling older population, frequent consumption of green tea was associated with a lower prevalence of depressive symptoms. [107]
4. In male Albino Wistar rats, oral administration of green tea leaf extract for 5 weeks produced anti-anxiety effects. [108]
5. In adult mice, administration of green tea polyphenols for 7 days produced antidepressant-like effects. [109]

References:

1. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5:13. Published 2010 Apr 6. doi:10.1186/1749-8546-5-13.
2. Suzuki Y, Miyoshi N, Isemura M. Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(3):88-101. doi:10.2183/pjab.88.88.
3. Haidari F, Omidian K, Rafiei H, Zarei M, Mohamad Shahi M. Green Tea (Camellia sinensis) Supplementation to Diabetic Rats Improves Serum and Hepatic Oxidative Stress Markers. Iran J Pharm Res. 2013;12(1):109-114.
4. Fu QY, Li QS, Lin XM, et al. Antidiabetic Effects of Tea. Molecules. 2017;22(5):849. Published 2017 May 20. doi:10.3390/molecules22050849.
5. Meng JM, Cao SY, Wei XL, et al. Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review. Antioxidants (Basel). 2019;8(6):170. Published 2019 Jun 10. doi:10.3390/antiox8060170.
6. Gao, Junjie, et al. “Combined Effects of Green Tea Extracts, Green Tea Polyphenols or Epigallocatechin Gallate With Acarbose On Inhibition Against Α-amylase and Α-glucosidase in Vitro.” Molecules (Basel, Switzerland), vol. 18, no. 9, 2013, pp. 11614-23.
7. Huang, J., Wang, Y., Xie, Z. et al. The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur J Clin Nutr 68, 1075–1087 (2014). https://doi.org/10.1038/ejcn.2014.143.
8. Kai Liu, Rui Zhou, Bin Wang, Ka Chen, Lin-Ying Shi, Jun-Dong Zhu, Man-Tian Mi, Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials, The American Journal of Clinical Nutrition, Volume 98, Issue 2, August 2013, Pages 340–348, https://doi.org/10.3945/ajcn.112.052746.
9. Peng X, Zhou R, Wang B, et al. Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep. 2014;4:6251. Published 2014 Sep 1. doi:10.1038/srep06251.
10. Xu R, Yang K, Ding J, Chen G. Effect of green tea supplementation on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020;99(6):e19047. doi:10.1097/MD.0000000000019047.
11. Li G, Zhang Y, Thabane L, et al. Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis. J Hypertens. 2015;33(2):243-254. doi:10.1097/HJH.0000000000000426.
12. Li D, Wang R, Huang J, et al. Effects and Mechanisms of Tea Regulating Blood Pressure: Evidences and Promises. Nutrients. 2019;11(5):1115. Published 2019 May 18. doi:10.3390/nu11051115.
13. Naderi Nabi B, Sedighinejad A, Haghighi M, Farzi F, Rimaz S, et al. The Anti-Obesity Effects of Green Tea: A Controlled, Randomized, Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(1):e55950. doi: 10.5812/ircmj.55950.
14. Huang, L., Liu, C., Wang, L. et al. Effects of green tea extract on overweight and obese women with high levels of low density-lipoprotein-cholesterol (LDL-C): a randomised, double-blind, and cross-over placebo-controlled clinical trial. BMC Complement Altern Med 18, 294 (2018). https://doi.org/10.1186/s12906-018-2355-x.
15. Available from https://journals.physiology.org/doi/full/10.1152/ajpregu.00832.2005?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&.
16. Das SK, Karmakar SN. Effect of green tea (camellia sinensis l.) leaf extract on reproductive system of adult male albino rats. Int J Physiol Pathophysiol Pharmacol. 2015;7(4):178-184. Published 2015 Dec 25.
17. Neves D, Assunção M, Marques F, Andrade JP, Almeida H. Does regular consumption of green tea influence expression of vascular endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for vasculogenic erectile dysfunction progression. Age (Dordr). 2008;30(4):217-228. doi:10.1007/s11357-008-9051-6.
18. Chen D, Zhang KQ, Li B, Sun DQ, Zhang H, Fu Q. Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway. Asian J Androl. 2017;19(3):291-297. doi:10.4103/1008-682X.178486.
19. Oboh G, Ademiluyi AO, Oyeleye SI, Olasehinde TA, Boligon AA. Modulation of some markers of erectile dysfunction and malonaldehyde levels in isolated rat penile tissue with unripe and ripe plantain peels: identification of the constituents of the plants using HPLC. Pharm Biol. 2017;55(1):1920-1926. doi:10.1080/13880209.2017.1340966.
20. Available from https://www.wjgnet.com/2220-3168/full/v3/i4/32.htm.
21. Prasanth MI, Sivamaruthi BS, Chaiyasut C, Tencomnao T. A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy. Nutrients. 2019;11(2):474. Published 2019 Feb 23. doi:10.3390/nu11020474.
22. Mostafa T, Sabry D, Abdelaal AM, Mostafa I, Taymour M. Cavernous antioxidant effect of green tea, epigallocatechin-3-gallate with/without sildenafil citrate intake in aged diabetic rats. Andrologia. 2013 Aug;45(4):272-7. doi: 10.1111/and.12005. Epub 2012 Aug 29. PMID: 22928786.
23. Mahmoudi R, Azizi A, Abedini S, Hemayatkhah Jahromi V, Abidi H, Jafari Barmak M. Green tea improves rat sperm quality and reduced cadmium chloride damage effect in spermatogenesis cycle. J Med Life. 2018;11(4):371-380. doi:10.25122/jml-2018-0005.
24. Available from https://www.nature.com/articles/s41598-020-72319-6.
25. Hajiaghaalipour F, Kanthimathi MS, Abdulla MA, Sanusi J. The Effect of Camellia sinensis on Wound Healing Potential in an Animal Model. Evid Based Complement Alternat Med. 2013;2013:386734. doi:10.1155/2013/386734.
26. Asadi SY, Parsaei P, Karimi M, et al. Effect of green tea (Camellia sinensis) extract on healing process of surgical wounds in rat. Int J Surg. 2013;11(4):332-337. doi:10.1016/j.ijsu.2013.02.014.
27. Reygaert WC. Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases. Biomed Res Int. 2018;2018:9105261. Published 2018 Jul 17. doi:10.1155/2018/9105261.
28. Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules. 2018;23(6):1297. Published 2018 May 29. doi:10.3390/molecules23061297.
29. Tang GY, Meng X, Gan RY, et al. Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review. Int J Mol Sci. 2019;20(24):6196. Published 2019 Dec 8. doi:10.3390/ijms20246196.
30. Chen L, Mo H, Zhao L, et al. Therapeutic properties of green tea against environmental insults. J Nutr Biochem. 2017;40:1-13. doi:10.1016/j.jnutbio.2016.05.005.
31. Lee J, Kim Y. Association between Green Tea Consumption and Risk of Stroke in Middle-Aged and Older Korean Men: The Health Examinees (HEXA) Study. Prev Nutr Food Sci. 2019;24(1):24-31. doi:10.3746/pnf.2019.24.1.24.
32. Shen L, Song LG, Ma H, Jin CN, Wang JA, Xiang MX. Tea consumption and risk of stroke: a dose-response meta-analysis of prospective studies. J Zhejiang Univ Sci B. 2012;13(8):652-662. doi:10.1631/jzus.B1201001.
33. Fraser ML, Mok GS, Lee AH. Green tea and stroke prevention: emerging evidence. Complement Ther Med. 2007 Mar;15(1):46-53. doi: 10.1016/j.ctim.2006.07.002. Epub 2006 Aug 30. PMID: 17352971.
34. Yao C, Zhang J, Liu G, Chen F, Lin Y. Neuroprotection by (-)-epigallocatechin-3-gallate in a rat model of stroke is mediated through inhibition of endoplasmic reticulum stress. Mol Med Rep. 2014 Jan;9(1):69-76. doi: 10.3892/mmr.2013.1778. Epub 2013 Nov 6. PMID: 24193141.
35. Tanabe N, Suzuki H, Aizawa Y, Seki N. Consumption of green and roasted teas and the risk of stroke incidence: results from the Tokamachi-Nakasato cohort study in Japan. Int J Epidemiol. 2008 Oct;37(5):1030-40. doi: 10.1093/ije/dyn211. PMID: 18832387.
36. Pang J, Zhang Z, Zheng TZ, Bassig BA, Mao C, Liu X, Zhu Y, Shi K, Ge J, Yang YJ, Dejia-Huang, Bai M, Peng Y. Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis. Int J Cardiol. 2016 Jan 1;202:967-74. doi: 10.1016/j.ijcard.2014.12.176. Epub 2015 Jan 4. PMID: 26318390.
37. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke. 2009 May;40(5):1786-92. doi: 10.1161/STROKEAHA.108.538470. Epub 2009 Feb 19. PMID: 19228856.
38. Ikeda A, Iso H, Yamagishi K, Iwasaki M, Yamaji T, Miura T, Sawada N, Inoue M, Tsugane S; JPHC Study Group. Plasma tea catechins and risk of cardiovascular disease in middle-aged Japanese subjects: The JPHC study. Atherosclerosis. 2018 Oct;277:90-97. doi: 10.1016/j.atherosclerosis.2018.08.001. Epub 2018 Aug 17. PMID: 30176569.
39. Tian C, Huang Q, Yang L, Légaré S, Angileri F, Yang H, Li X, Min X, Zhang C, Xu C, Yuan J, Miao X, He MA, Wu T, Zhang X. Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort. Sci Rep. 2016 Apr 13;6:24353. doi: 10.1038/srep24353. Erratum in: Sci Rep. 2017 May 31;7:45949. PMID: 27072746; PMCID: PMC4829846.
40. Pang J, Zhang Z, Zheng T, et al. Association of green tea consumption with risk of coronary heart disease in Chinese population. Int J Cardiol. 2015;179:275-278. doi:10.1016/j.ijcard.2014.11.093.
41. Babu PV, Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem. 2008;15(18):1840-1850. doi:10.2174/092986708785132979.
42. Cao SY, Zhao CN, Gan RY, et al. Effects and Mechanisms of Tea and Its Bioactive Compounds for the Prevention and Treatment of Cardiovascular Diseases: An Updated Review. Antioxidants (Basel). 2019;8(6):166. Published 2019 Jun 6. doi:10.3390/antiox8060166.
43. Li X, Yu C, Guo Y, et al. Tea consumption and risk of ischaemic heart disease. Heart. 2017;103(10):783-789. doi:10.1136/heartjnl-2016-310462.
44. Available from https://www.researchgate.net/publication/273302242_Green_tea_catechins_and_cardiovascular_disease_risk_factors_Should_a_health_claim_be_made_by_the_United_States_Food_and_Drug_Administration.
45. Kakutani S, Watanabe H, Murayama N. Green Tea Intake and Risks for Dementia, Alzheimer’s Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review. Nutrients. 2019;11(5):1165. Published 2019 May 24. doi:10.3390/nu11051165.
46. Polito CA, Cai ZY, Shi YL, et al. Association of Tea Consumption with Risk of Alzheimer’s Disease and Anti-Beta-Amyloid Effects of Tea. Nutrients. 2018;10(5):655. Published 2018 May 22. doi:10.3390/nu10050655.
47. Pervin M, Unno K, Ohishi T, Tanabe H, Miyoshi N, Nakamura Y. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases. Molecules. 2018;23(6):1297. Published 2018 May 29. doi:10.3390/molecules23061297.
48. Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S. Green tea effects on cognition, mood and human brain function: A systematic review. Phytomedicine. 2017 Oct 15;34:26-37. doi: 10.1016/j.phymed.2017.07.008. Epub 2017 Jul 27. PMID: 28899506.
49. Shirai Y, Kuriki K, Otsuka R, Kato Y, Nishita Y, Tange C, Tomida M, Imai T, Ando F, Shimokata H. Green tea and coffee intake and risk of cognitive decline in older adults: the National Institute for Longevity Sciences, Longitudinal Study of Aging. Public Health Nutr. 2020 Apr;23(6):1049-1057. doi: 10.1017/S1368980019002659. Epub 2019 Sep 23. PMID: 31544736.
50. Bao J, Liu W, Zhou HY, Gui YR, Yang YH, Wu MJ, Xiao YF, Shang JT, Long GF, Shu XJ. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice. Curr Med Sci. 2020 Feb;40(1):18-27. doi: 10.1007/s11596-020-2142-z. Epub 2020 Mar 13. PMID: 32166661.
51. Cascella M, Bimonte S, Muzio MR, Schiavone V, Cuomo A. The efficacy of Epigallocatechin-3-gallate (green tea) in the treatment of Alzheimer’s disease: an overview of pre-clinical studies and translational perspectives in clinical practice. Infect Agent Cancer. 2017;12:36. Published 2017 Jun 19. doi:10.1186/s13027-017-0145-6.
52. Ayaz M, Sadiq A, Junaid M, et al. Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders. Front Aging Neurosci. 2019;11:155. Published 2019 Jun 26. doi:10.3389/fnagi.2019.00155.
53. Khan N, Mukhtar H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev. 2010;29(3):435-445. doi:10.1007/s10555-010-9236-1.
54. Fujiki H, Watanabe T, Sueoka E, Rawangkan A, Suganuma M. Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells. Mol Cells. 2018;41(2):73-82. doi:10.14348/molcells.2018.2227.
55. Sato D. Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea. Int. J. Urol. 1999;6:93–99. doi: 10.1046/j.1442-2042.1999.06239.x.
56. Sato D., Matsushima M. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves. Int. J. Urol. 2003;10:160–166. doi: 10.1046/j.1442-2042.2003.00587.x.
57. Sagara Y., Miyata Y., Nomata K., Hayashi T., Kanetake H. Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer. Cancer Epidemiol. 2010;34:350–354. doi: 10.1016/j.canep.2010.03.001.
58. Henriques A., Arantes-Rodrigues R., Faustino-Rocha A.I., Teixeira-Guedes C.I., Pinho-Oliveira J., Talhada D., Teixeira J.H., Andrade A., Colaço B., Paiva-Cardoso M.N., et al. The effects of whole green tea infusion on mouse urinary bladder chemical carcinogenesis. Iran. J. Basic Med. Sci. 2014;17:145–148.
59. Matsuo T., Miyata Y., Asai A., Sagara Y., Furusato B., Fukuoka J., Sakai H. Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer. PLoS ONE. 2017;12:0171091. doi: 10.1371/journal.pone.0171091.
60. Kemberling J.K., Hampton J.A., Keck R.W., Gomez M.A., Selman S.H. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J. Urol. 2003;170:773–776. doi: 10.1097/01.ju.0000081278.64511.96.
61. Rieger-Christ K.M., Hanley R., Lodowsky C., Bernier T., Vemulapalli P., Roth M., Kim J., Yee A.S., Le S.M., Marie P.J., et al. The green tea compound, (−)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. J. Cell Biochem. 2007;102:377–388. doi: 10.1002/jcb.21299.
62. Chen N.G., Lu C.C., Lin Y.H., Shen W.C., Lai C.H., Ho Y.J., Chung J.G., Lin T.H., Lin Y.C., Yang J.S. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: Roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Oncol. Rep. 2011;26:939–947.
63. Hsieh D.S., Wang H., Tan S.W., Huang Y.H., Tsai C.Y., Yeh M.K., Wu C.J. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Biomaterials. 2011;32:7633–7640. doi: 10.1016/j.biomaterials.2011.06.073.
64. Fujiki H, Sueoka E, Watanabe T, Suganuma M. Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compounds. J Cancer Prev. 2015;20(1):1-4. doi:10.15430/JCP.2015.20.1.1.
65. Sadava D., Whitlock E., Kane S.E. The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells. Biochem. Biophys. Res. Commun. 2007;360:233–237. doi: 10.1016/j.bbrc.2007.06.030.
66. Milligan S.A., Burke P., Coleman D.T., Bigelow R.L., Steffan J.J., Carroll J.L., Williams B.J., Cardelli J.A. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin. Cancer Res. 2009;15:4885–4894. doi: 10.1158/1078-0432.CCR-09-0109.
67. Shim J.H., Su Z.Y., Chae J.I., Kim D.J., Zhu F., Ma W.Y., Bode A.M., Yang C.S., Dong Z. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev. Res. 2010;3:670–679. doi: 10.1158/1940-6207.CAPR-09-0185.
68. Liao J., Yang G.Y., Park E.S., Meng X., Sun Y., Jia D., Seril D.N., Yang C.S. Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer. 2004;48:44–53. doi: 10.1207/s15327914nc4801_7.
69. Lu G., Liao J., Yang G., Reuhl K.R., Hao X., Yang C.S. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006;66:11494–11501. doi: 10.1158/0008-5472.CAN-06-1497.
70. Manna S., Mukherjee S., Roy A., Das S., Panda C.K. Tea polyphenols can restrict benzo[a]pyrene-induced lung carcinogenesis by altered expression of p53-associated genes and H-ras, c-myc and cyclin D1. J. Nutr. Biochem. 2009;20:337–349. doi: 10.1016/j.jnutbio.2008.04.001.
71. Mimoto J., Kiura K., Matsuo K., Yoshino T., Takata I., Ueoka H., Kataoka M., Harada M. (−)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigenesis in A/J mice. Carcinogenesis. 2000;21:915–919. doi: 10.1093/carcin/21.5.915.
72. Wang Z.Y., Hong J.Y., Huang M.T., Reuhl K.R., Conney A.H., Yang C.S. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 1992;52:1943–1947.
73. Chen C., Shen G., Hebbar V., Hu R., Owuor E.D., Kong A.N. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis. 2003;24:1369–1378. doi: 10.1093/carcin/bgg091.
74. Shimizu M., Deguchi A., Lim J.T., Moriwaki H., Kopelovich L., Weinstein I.B. (−)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 2005;11:2735–2746. doi: 10.1158/1078-0432.CCR-04-2014.
75. Shimizu M., Shirakami Y., Sakai H., Yasuda Y., Kubota M., Adachi S., Tsurumi H., Hara Y., Moriwaki H. (−)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem. Biol. Interact. 2010;185:247–252. doi: 10.1016/j.cbi.2010.03.036.
76. Jia X., Han C. Effects of green tea on colonic aberrant crypt foci and proliferative indexes in rats. Nutr. Cancer. 2001;39:239–243. doi: 10.1207/S15327914nc392_13.
77. Ohishi T., Kishimoto Y., Miura N., Shiota G., Kohri T., Hara Y., Hasegawa J., Isemura M. Synergistic effects of (−)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane. Cancer Lett. 2002;177:49–56. doi: 10.1016/S0304-3835(01)00767-4.
78. Shirakami Y., Shimizu M., Tsurumi H., Hara Y., Tanaka T., Moriwaki H. EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS. Mol. Med. Rep. 2008;1:355–361. doi: 10.3892/mmr.1.3.355.
79. Shimizu M., Shirakami Y., Sakai H., Adachi S., Hata K., Hirose Y., Tsurumi H., Tanaka T., Moriwaki H. (−)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev. Res. 2008;1:298–304. doi: 10.1158/1940-6207.CAPR-08-0045.
80. Siddiqui I.A., Malik A., Adhami V.M., Asim M., Hafeez B.B., Sarfaraz S., Mukhtar H. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene. 2008;27:2055–2063. doi: 10.1038/sj.onc.1210840.
81. Lee S.C., Chan W.K., Lee T.W., Lam W.H., Wang X., Chan T.H., Wong Y.C. Effect of a prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr. Cancer. 2008;60:483–491. doi: 10.1080/01635580801947674.
82. Liao S., Umekita Y., Guo J., Kokontis J.M., Hiipakka R.A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995;96:239–243. doi: 10.1016/0304-3835(95)03948-V.
83. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: Evaluation of tumor growth and immunohistochemistry. In Vivo. 2005;19:179–183.
84. Gupta S., Hastak K., Ahmad N., Lewin J.S., Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA. 2001;98:10350–10355. doi: 10.1073/pnas.171326098.
85. Caporali A., Davalli P., Astancolle S., D’Arca D., Brausi M., Bettuzzi S., Corti A. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis. 2004;25:2217–2224. doi: 10.1093/carcin/bgh235.
86. Miyata Y, Shida Y, Hakariya T, Sakai H. Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer. Molecules. 2019;24(1):193. Published 2019 Jan 7. doi:10.3390/molecules24010193.
87. Bonuccelli G, Sotgia F, Lisanti MP. Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways. Aging (Albany NY). 2018;10(8):1867-1883. doi:10.18632/aging.101483.
88. Gianfredi V, Nucci D, Abalsamo A, et al. Green Tea Consumption and Risk of Breast Cancer and Recurrence-A Systematic Review and Meta-Analysis of Observational Studies. Nutrients. 2018;10(12):1886. Published 2018 Dec 3. doi:10.3390/nu10121886.
89. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis. 2006 Jul;27(7):1310-5. doi: 10.1093/carcin/bgi276. Epub 2005 Nov 25. PMID: 16311246.
90. Shrubsole MJ, Lu W, Chen Z, et al. Drinking green tea modestly reduces breast cancer risk. J Nutr. 2009;139(2):310-316. doi:10.3945/jn.108.098699.
91. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998 Mar;89(3):254-61. doi: 10.1111/j.1349-7006.1998.tb00556.x. PMID: 9600118; PMCID: PMC5921805.
92. Zhang G, Wang Y, Zhang Y, et al. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med. 2012;12(2):163-176. doi:10.2174/156652412798889063.
93. Li MJ, Yin YC, Wang J, Jiang YF. Green tea compounds in breast cancer prevention and treatment. World J Clin Oncol. 2014;5(3):520-528. doi:10.5306/wjco.v5.i3.520.
94. Li F, Wang Y, Li D, et al. Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov. 2018;13(7):643-660. doi:10.1080/17460441.2018.1465923.
95. Dou QP. Molecular mechanisms of green tea polyphenols. Nutr Cancer. 2009;61(6):827-835. doi:10.1080/01635580903285049.
96. Khan N, Mukhtar H. Tea Polyphenols in Promotion of Human Health. Nutrients. 2018;11(1):39. Published 2018 Dec 25. doi:10.3390/nu11010039.
97. Singhal K, Raj N, Gupta K, Singh S. Probable benefits of green tea with genetic implications. J Oral Maxillofac Pathol. 2017;21(1):107-114. doi:10.4103/0973-029X.203758.
98. Yuan JM. Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr. 2013 Dec;98(6 Suppl):1676S-1681S. doi: 10.3945/ajcn.113.058271. Epub 2013 Oct 30. PMID: 24172305; PMCID: PMC3831544.
99. Tsao AS, Liu D, Martin J, et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila). 2009;2(11):931-941. doi:10.1158/1940-6207.CAPR-09-0121.
100. Yuan JM. Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr. 2013;98(6 Suppl):1676S-1681S. doi:10.3945/ajcn.113.058271.
101. Chen D, Wan SB, Yang H, Yuan J, Chan TH, Dou QP. EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem. 2011;53:155-177. doi:10.1016/b978-0-12-385855-9.00007-2.
102. Johnson JJ, Bailey HH, Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine. 2010;17(1):3-13. doi:10.1016/j.phymed.2009.09.011.
103. Suganuma M, Ohkura Y, Okabe S, Fujiki H. Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice. J Cancer Res Clin Oncol. 2001 Jan;127(1):69-72. doi: 10.1007/s004320000189. PMID: 11206275.
104. Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr. 2013 Dec;32(6):894-903. doi: 10.1016/j.clnu.2013.03.008. Epub 2013 Mar 15. PMID: 23582951.
105. Zhang Q, Yang H, Wang J, et al. Effect of green tea on reward learning in healthy individuals: a randomized, double-blind, placebo-controlled pilot study. Nutr J. 2013;12:84. Published 2013 Jun 18. doi:10.1186/1475-2891-12-84.
106. Rothenberg DO, Zhang L. Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption. Nutrients. 2019;11(6):1361. Published 2019 Jun 17. doi:10.3390/nu11061361.
107. Niu K, Hozawa A, Kuriyama S, Ebihara S, Guo H, Nakaya N, Ohmori-Matsuda K, Takahashi H, Masamune Y, Asada M, Sasaki S, Arai H, Awata S, Nagatomi R, Tsuji I. Green tea consumption is associated with depressive symptoms in the elderly. Am J Clin Nutr. 2009 Dec;90(6):1615-22. doi: 10.3945/ajcn.2009.28216. Epub 2009 Oct 14. PMID: 19828710.
108. Mirza B, Ikram H, Bilgrami S, Haleem DJ, Haleem MA. Neurochemical and behavioral effects of green tea (Camellia sinensis): a model study. Pak J Pharm Sci. 2013 May;26(3):511-6. PMID: 23625424.
109. Zhu WL, Shi HS, Wei YM, Wang SJ, Sun CY, Ding ZB, Lu L. Green tea polyphenols produce antidepressant-like effects in adult mice. Pharmacol Res. 2012 Jan;65(1):74-80. doi: 10.1016/j.phrs.2011.09.007. Epub 2011 Sep 22. PMID: 21964320.